Catalent Biologics and Humanigen to Present a Case Study on Accelerated Scale Up of a Monoclonal Antibody to Treat COVID-19 at BioProcess International Conference

The COVID-19 pandemic has seen innovators looking to accelerate timelines in order to bring safe and effective potential therapies to patients quickly.